Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Dept Of Ophthalmology, |
RCV003891174 | SCV004704860 | likely pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Ambry Genetics | RCV004369718 | SCV004893540 | uncertain significance | Inborn genetic diseases | 2023-12-30 | criteria provided, single submitter | clinical testing | The c.2132C>T (p.P711L) alteration is located in exon 2 (coding exon 2) of the KIAA1549 gene. This alteration results from a C to T substitution at nucleotide position 2132, causing the proline (P) at amino acid position 711 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |